Analysis of Microplastics in Human Feces Reveals a Correlation between Fecal Microplastics and Inflammatory Bowel

Zehua Yan1, Yafei Liu2, Ting Zhang2

  • 1State Key Laboratory of Pollution Control and Resource Reuse, School of the Environment, Nanjing University, Nanjing 210023, China.

Insights

Human fecal microplastic (MP) levels are higher in inflammatory bowel disease (IBD) patients than in healthy individuals. This study links MP exposure to IBD severity, suggesting MPs may influence the disease process.

Area of Science:

  • Environmental Health
  • Gastroenterology
  • Toxicology

Background:

  • Microplastic (MP) ubiquity in food and water makes human ingestion unavoidable.
  • The health risks associated with MP ingestion remain largely unknown.
  • Inflammatory bowel disease (IBD) is a chronic condition affecting the digestive tract.

Purpose of the Study:

  • To compare MP concentrations in the feces of IBD patients and healthy individuals.
  • To investigate the correlation between fecal MP characteristics and IBD severity.
  • To identify potential sources of human MP exposure.

Main Methods:

  • Analysis of microplastic characteristics in fecal samples from IBD patients and healthy controls.
  • Quantification of MP types, shapes, and concentrations.
  • Correlation analysis between MP levels and IBD status.
  • Questionnaire survey to assess potential exposure sources.

Main Results:

  • Fecal MP concentration was significantly higher in IBD patients (41.8 items/g dry matter) compared to healthy individuals (28.0 items/g dry matter).
  • Poly(ethylene terephthalate) and polyamide were the dominant MP types, primarily in sheet and fiber shapes.
  • A positive correlation was observed between fecal MP concentration and IBD severity.
  • Plastic packaging and dust exposure were identified as significant sources of human MP exposure.

Conclusions:

  • Fecal microplastic levels are elevated in individuals with IBD.
  • A correlation exists between microplastic exposure and IBD, suggesting MPs may play a role in disease development or retention.
  • Fecal MPs serve as a valuable indicator for assessing human exposure and potential health risks.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
445
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
405
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
537
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
560